Medical Communications

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

The search for a COVID-19 treatment has ramped up this week, with two new studies detailing the efficacy of Gilead’s …

The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!

There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …

Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …

Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …

National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …

President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …

The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals …

Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …